Clinical Trial: CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure

U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07727759) titled 'CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure' on July 16.

Brief Summary: Removing a large part of the liver (major hepatectomy) can cure primary and secondary liver cancers, but it carries the risk of post-hepatectomy liver failure (PHLF), a serious complication in which the liver left behind - the future liver remnant (FLR) - cannot meet the body's metabolic needs. PHLF occurs after roughly 5% to 15% of major hepatectomies and is the leading cause of postoperative death.

Before surgery, surgeons routinely use CT scans to measure how much liver will remain (CT volumetry). Volume al...